| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 47.602 | 49.196 | 54.932 | 56.078 | 48.719 | 58.067 | 57.305 | 65.368 |
| Total Income - EUR | 0 | 0 | 47.602 | 49.338 | 55.046 | 56.084 | 48.719 | 59.180 | 58.604 | 68.044 |
| Total Expenses - EUR | 0 | 0 | 43.550 | 43.424 | 52.168 | 48.342 | 42.442 | 50.508 | 51.741 | 61.525 |
| Gross Profit/Loss - EUR | 0 | 0 | 4.052 | 5.915 | 2.878 | 7.742 | 6.277 | 8.672 | 6.863 | 6.519 |
| Net Profit/Loss - EUR | 0 | 0 | 3.576 | 5.421 | 2.327 | 7.222 | 5.843 | 8.092 | 6.347 | 5.639 |
| Employees | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biomirnut Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 148 | 146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11.111 | 143 | 9.956 | 10.119 | 14.880 | 15.793 | 15.690 | 8.304 | 12.487 | 15.263 |
| Inventories | 0 | 0 | 8.744 | 7.536 | 7.616 | 7.479 | 7.482 | 6.213 | 8.391 | 9.291 |
| Receivables | 10.967 | 0 | 1.043 | 1.024 | 6.896 | 7.604 | 8.028 | 367 | 3.568 | 4 |
| Cash | 144 | 143 | 169 | 1.559 | 369 | 710 | 180 | 1.724 | 528 | 5.968 |
| Shareholders Funds | 2.812 | 289 | 3.693 | 9.047 | 11.199 | 14.074 | 14.147 | 6.060 | 8.548 | 14.139 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.446 | 0 | 6.263 | 1.073 | 3.681 | 1.719 | 1.543 | 2.243 | 3.939 | 1.124 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Biomirnut Srl